|
Index of reports
> Cases resulting in other serious reactions (706)
> Cases with Breast Cancer (262)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in other serious reactions where reactions include breast cancer.
Reports 1 - 25 of 262 Next >>
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-31
Patient: female, weighing 74.9 kg (164.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2002-03-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer, Lung Neoplasm Malignant, Myocardial Infarction, Cerebrovascular Accident
Suspect drug(s):
Estrogen NOS
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in 36 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 36 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 55 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 55 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 56 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Adverse event in 55 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 55 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female, weighing 737.8 kg (1623.1 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 53 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 36 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 36 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient:
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Amen
Cycrin
Medroxyprogesterone
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Medroxyprogesterone
Indication: Hormone Replacement Therapy
Premarin
Indication: Oestrogen Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 50 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 50 year old female, weighing 113.5 kg (249.7 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Atenolol; Lisinopril; Hydrochlorothiazide; Cardura; Lantus
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 62 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 62 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Prempro
Provera
Adverse event in 48 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Medroxyprogesterone
Indication: Hormone Replacement Therapy
Norethindrone Acetate
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Premphase 14 / 14
Indication: Hormone Replacement Therapy
Prometrium
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 49 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 49 year old female, weighing 77.2 kg (169.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Premarin
Indication: Hormone Replacement Therapy
Start date: 1994-04-14
End date: 1998-05-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1994-01-27
End date: 1998-05-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 63 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-05-22
End date: 1998-03-11
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-03-01
End date: 1989-05-24
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Adverse event in 49 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 49 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 53 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Page 1 Next >>
|
